Gut-Microbiota-Metabolite Axis in Early Renal Function Decline.

Area of Science:

• Microbiology
• Nephrology
• Metabolomics

Background:

• Bacterial protein fermentation metabolites are linked to reduced renal function, but timing and severity remain unclear.
• Investigating specific metabolites like indoxyl-sulfate, p-cresyl-sulfate, and phenylacetylglutamine in early renal decline is crucial.

Purpose of the Study:

• To explore the relationship between indoxyl-sulfate, p-cresyl-sulfate, phenylacetylglutamine, and gut microbial profiles in individuals with early renal function decline.

Main Methods:

• Analysis of metabolite associations with 16S gut microbiome profiles in a large cohort (n=4439) with minimal renal function decline.
• Utilized QIIME 1.7.0 for microbiome profiling and statistical analysis to identify significant associations.

Main Results:

• Indoxyl-sulfate, p-cresyl-sulfate, and phenylacetylglutamine showed inverse associations with estimated glomerular filtration rate (eGFR).
• Significant associations were found between these metabolites and specific gut microbial Operational Taxonomic Units (OTUs), primarily within the order Clostridiales.
• Three microbes were also directly associated with eGFR, suggesting a link between gut flora and kidney function.

Conclusions:

• Indoxyl-sulfate, p-cresyl-sulfate, and phenylacetylglutamine serve as early markers for renal function decline.
• Alterations in intestinal flora associated with these metabolites are detectable in the early stages of kidney disease.
• Further research is needed to leverage these findings for improved early diagnostics and therapeutic strategies in nephrology.